EUVIMEDEUVIMED entdecken
Open Access · CC BY-SA 4.0

The Comparison of Impact of Myo-inositol in combination with Metformin versus Metformin alone on Androgenic Features of PCOS patients

Hira Ehsan Khattak, Syeda Khadija Mahrukh, Atif Ullah, Muhammad Zahid, Sadia Gul, Ayesha Khan

Journal of Rawalpindi Medical College · 31.03.2026 · 30 (1)

DOI: 10.37939/jrmc.v30i1.2948 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Rawalpindi Medical College, online erschienen am 31.03.2026. Verfasst von Hira Ehsan Khattak und 5 weiteren Autor:innen. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-SA 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To compare the effects of a combination of Myo-inositol and Metformin versus Metformin alone on hirsutism and acne in PCOS patients.

Methods

A total of 114 adult PCOS patients with hirsutism as well as acne underwent an 8-months randomization (September 2022 to May 2023) at Khyber Teaching hospital Peshawar outpatient department of gynecology and obstetrics, to one of the two treatments (double blinded study), where Group A included of 57 individuals taking combination of 500 mg of oral Metformin three times each day and Myo-inositol 4000 mg once daily; Group B included 57 individuals taking 500 mg of oral Metformin three times each day as single therapy. All hormonal, metabolic, and clinical indicators were assessed at the initial and eight-month points after the commencement of medication.

Results

A Significant difference was noted in terms of mean change in Farriman-Gallwey score in Group A (n=55), 3.59±0.81, versus Group B (n=54), 4.68±0.55 (p=0.00). Similarly, there was a notable improvement in mean change in Global acne score in Group A 1.51±0.50 when compared to Group B 2.38±0.67 (p =0.00), similarly there was significant differences between Group A 33.2±3.01 and Group B 41.5±32.99 in terms of mean serum Total testosterone levels p=0.00 and significant difference between Group A 95.56±5.71 and Group B 146.70±15.75 in terms of mean serum DHEA levels p=0.00.

Conclusion

By balancing hormones and improving metabolic profile, Myo-inositol and Metformin, when used in combination, are more successful in treating hirsutism and acne in adult PCOS patients as compared to metformin alone. Keywords: Polycystic ovarian syndrome, hirsutism, myo-inositol, metformin

Zitieren

APA

Khattak, H. E., Mahrukh, S. K., Ullah, A., Zahid, M., Gul, S., & Khan, A. (2026). The Comparison of Impact of Myo-inositol in combination with Metformin versus Metformin alone on Androgenic Features of PCOS patients. Journal of Rawalpindi Medical College, 30(1). https://doi.org/10.37939/jrmc.v30i1.2948

Vancouver

Khattak HE, Mahrukh SK, Ullah A, Zahid M, Gul S, Khan A. The Comparison of Impact of Myo-inositol in combination with Metformin versus Metformin alone on Androgenic Features of PCOS patients. Journal of Rawalpindi Medical College. 2026;30(1). doi:10.37939/jrmc.v30i1.2948

BibTeX
@article{Khattak2026,
  author = {Khattak, Hira Ehsan and Mahrukh, Syeda Khadija and Ullah, Atif and Zahid, Muhammad and Gul, Sadia and Khan, Ayesha},
  title = {The Comparison of Impact of Myo-inositol in combination with Metformin versus Metformin alone on Androgenic Features of PCOS patients},
  journal = {Journal of Rawalpindi Medical College},
  year = {2026},
  volume = {30},
  number = {1},
  doi = {10.37939/jrmc.v30i1.2948}
}
Kostenlos starten →